Octaplas Solution
NDC Package 68982-952-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Octaplas (human plasma proteins) solution is octaplas is a solvent/ detergent (S/D) treated, pooled human plasma indicated for: Replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease undergoing cardiac surgery and liver transplant Plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP). This formulation utilizes a solution delivery system. Marketed by Octapharma Usa Inc, this product is identified by NDC 68982-952 and is authorized under FDA application BLA125416.

Identification & Billing

NDC Package Code
68982-952-01
Package Description
200 mL in 1 BAG
Product Code
68982-952
11-Digit Billing Format
68982095201
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
200 ML

Clinical Specifications

Proprietary Name
Octaplas
Non-Proprietary Name
Human Plasma Proteins
Substance Name
Plasma Protein Fraction (human)
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
PLASMA PROTEIN FRACTION (HUMAN) 11.5 g/200mL
Usage Information
Octaplas is a solvent/ detergent (S/D) treated, pooled human plasma indicated for: Replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease undergoing cardiac surgery and liver transplant Plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP)

Regulatory & Marketing

Labeler Name
Octapharma Usa Inc
Product Type
Plasma Derivative
FDA Application #
BLA125416
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
07-18-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68982-952-01 identifies a specific commercial package of 200 ml in 1 bag of Octaplas, a plasma derivative labeled by Octapharma Usa Inc. This product is billed per "ML" milliliter and contains an estimated amount of 200 billable units per package. This solution is formulated for intravenous use and contains plasma protein fraction (human) as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Octapharma Usa Inc on July 18, 2013. The current certification is valid through December 31, 2026.

How is this Octapharma Usa Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68982095201. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 200 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68982-952-01
11-Digit CMS (5-4-2)
68982-0952-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.